CSIMarket
 
Orasure Technologies Inc  (OSUR)
Other Ticker:  
 
 
Price: $5.8300 $0.05 0.865%
Day's High: $5.905 Week Perf: -3.64 %
Day's Low: $ 5.77 30 Day Perf: -6.27 %
Volume (M): 350 52 Wk High: $ 7.26
Volume (M$): $ 2,042 52 Wk Avg: $4.70
Open: $5.82 52 Wk Low: $2.62



 Market Capitalization (Millions $) 418
 Shares Outstanding (Millions) 72
 Employees -
 Revenues (TTM) (Millions $) 387
 Net Income (TTM) (Millions $) -18
 Cash Flow (TTM) (Millions $) -33
 Capital Exp. (TTM) (Millions $) 7

Orasure Technologies Inc


   Company Address: 220 East First Street Bethlehem 18015 PA
   Company Phone Number: 882-1820   Stock Exchange / Ticker: NASDAQ OSUR
   OSUR is expected to report next financial results on May 09, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Impel Pharmaceuticals Inc

In the most recent fiscal period company decreased a loss per share at $-0.98 per share, opposite of $-1.06 per share a year before financial reporting period, In the preceding financial reporting period Impel Pharmaceuticals Inc realized $-1.31 per share.

Cytomx Therapeutics Inc

Focusing on the financial interval ending December 31 2022 CTMX lost money at $-0.42 per share, relative to the results of $-0.91 per share a year before quarter, In the previous quarter CTMX realized $-0.35 per share.

Acer Therapeutics Inc

For the fiscal time-frame closing December 31 2022 Acer Therapeutics Inc increased a loss per share of $-0.54 per share compare to $-0.30 a year prior and grew loss from $-0.31 per share from the preceding reporting period.

Sales remained unaltered to $0.00 millions from $0.36 millions in the same reporting period a year prior and sequentially Sales Tumbled from $0.00 millions.

Pennsylvania Real Estate Investment Trust

A humbling fiscal period by the company amid the fourth quarter of 2022

For the fourth quarter of 2022 earnings season company Deficit has extended of $-7.81 per share compare to $-0.43 a year before and EPS improved from $-14.52 per share from the preceding quarter.

Sales depreciated by -5.307 % to $80.65 millions from $85.17 millions in the comparable quarter a year before and sequentially Sales advanced by 10.767 % from $72.81 millions.

Terns Pharmaceuticals Inc

For the financial period ending December 31 2022 company decreased a loss per share of $-0.23 per share compare to $-0.56 a year prior and EPS improved from $-0.44 per share from the preceding reporting period.

Sales remained unchanged to $0.00 millions from $1.00 millions in the corresponding reporting period a year prior and sequentially Sales advanced from $0.00 millions.






 

Orasure Technologies Inc's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GRPH's Profile

Stock Price

GRPH's Financials

Business Description

Fundamentals

Charts & Quotes

GRPH's News

Suppliers

GRPH's Competitors

Customers & Markets

Economic Indicators

GRPH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071